SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.
Mol Cancer Ther
; 20(9): 1508-1520, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-34210826
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peritoneal Neoplasms
/
Melanoma, Experimental
/
Interleukins
/
Interleukin-12
/
Mesenchymal Stem Cell Transplantation
/
Mesenchymal Stem Cells
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2021
Document type:
Article